These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6830911)

  • 21. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction of phosphatidyl serine with fibrin monomer].
    Mukhacheva IA; Byshevskiĭ ASh
    Biokhimiia; 1979 Nov; 44(11):1944-51. PubMed ID: 161862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biologically active low-molecular fragments of fibrinogen molecule].
    Musialkivs'ka AO; Platonova TM; Radavs'kiĭ IuL
    Ukr Biokhim Zh; 1977; 49(3):89-93. PubMed ID: 888231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
    Pozdniakova TM; Rybachuk VN; Vovk EV
    Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinogen and fibrin monomer conformation changes dependent of pH magnitude].
    Demchenko AP; Zima VL; Galanova TF; Belitser VA
    Mol Biol (Mosk); 1976; 10(2):305-13. PubMed ID: 7745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies in the fibrinogen molecule D fragment inactivation protecting fragment].
    Uharova TP; Smekhova KO; Musjalkivs'ka AO
    Ukr Biokhim Zh; 1977; 49(5):60-3. PubMed ID: 919058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
    Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen fragment D is necessary and sufficient to anchor a surface plasminogen-activating complex in Streptococcus pyogenes.
    Hess JL; Boyle MD
    Proteomics; 2006 Jan; 6(1):375-8. PubMed ID: 16287173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticlotting activity of fragment D from fibrinogen and fibrin and its dependence on calcium presence when fragments are obtained from fibrinogen].
    Tolstikh VM; Varets'ka TV
    Ukr Biokhim Zh; 1976; 48(1):116-21. PubMed ID: 1258156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modification of fibrin assembly as a method for studying the mechanism of this process].
    Belitser VO; Varetska TV
    Ukr Biokhim Zh; 1975; 47(5):567-79. PubMed ID: 1202701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.